136 related articles for article (PubMed ID: 8993544)
21. Targeted disruption of the peroxisome proliferator-activated receptor alpha gene, PPAR alpha.
Lee SS; Gonzalez FJ
Ann N Y Acad Sci; 1996 Dec; 804():524-9. PubMed ID: 8993570
[No Abstract] [Full Text] [Related]
22. Analysis of peroxisome proliferator-responsive enhancer of the rat acyl-CoA oxidase gene.
Osumi T; Osada S; Tsukamoto T
Ann N Y Acad Sci; 1996 Dec; 804():202-13. PubMed ID: 8993545
[No Abstract] [Full Text] [Related]
23. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
Tamura H; Iida T; Watanabe T; Suga T
Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
[TBL] [Abstract][Full Text] [Related]
24. Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor alpha (rPPAR alpha) activation and peroxisomal fatty acid beta-oxidation.
Rangwala SM; O'Brien ML; Tortorella V; Longo A; Loiodice F; Noonan DJ; Feller DR
Chirality; 1997; 9(1):37-47. PubMed ID: 9094202
[TBL] [Abstract][Full Text] [Related]
25. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
26. Unusual responses of rat hepatic and renal peroxisomes to RMI 14, 514, a new hypolipidemic agent.
Svoboda DJ
J Cell Biol; 1978 Sep; 78(3):810-22. PubMed ID: 29903
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptors: structures and function.
Tugwood JD; Aldridge TC; Lambe KG; Macdonald N; Woodyatt NJ
Ann N Y Acad Sci; 1996 Dec; 804():252-65. PubMed ID: 8993548
[TBL] [Abstract][Full Text] [Related]
28. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.
Peters JM; Cattley RC; Gonzalez FJ
Carcinogenesis; 1997 Nov; 18(11):2029-33. PubMed ID: 9395198
[TBL] [Abstract][Full Text] [Related]
29. Hypolipidemic effect of peroxisome proliferators. Transcriptional suppression of apolipoprotein C-III.
Hertz R; Bishara-Shieban J; Bar-Tana J
Ann N Y Acad Sci; 1996 Dec; 804():731-3. PubMed ID: 8993607
[No Abstract] [Full Text] [Related]
30. Pretreatment with peroxisome proliferators protects mice against some but not all hepatotoxins.
Nicholls-Grzemski FA; Burcham PC; Calder IC; Priestly BG
Ann N Y Acad Sci; 1996 Dec; 804():742-4. PubMed ID: 8993611
[No Abstract] [Full Text] [Related]
31. Peroxisome proliferators and cytochrome P4504A induction.
Gibson GG
Ann N Y Acad Sci; 1996 Dec; 804():328-40. PubMed ID: 8993554
[No Abstract] [Full Text] [Related]
32. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals.
Corton JC; Fan LQ; Brown S; Anderson SP; Bocos C; Cattley RC; Mode A; Gustafsson JA
Mol Pharmacol; 1998 Sep; 54(3):463-73. PubMed ID: 9730905
[TBL] [Abstract][Full Text] [Related]
33. [The mechanism of action of hypolipidemic drugs].
Scheen AJ
Rev Med Liege; 1997 Jun; 52(6):445-6. PubMed ID: 9289779
[No Abstract] [Full Text] [Related]
34. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression.
Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA
Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475
[TBL] [Abstract][Full Text] [Related]
35. DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.
Fahl WE; Lalwani ND; Watanabe T; Goel SK; Reddy JK
Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7827-30. PubMed ID: 6096860
[TBL] [Abstract][Full Text] [Related]
36. [Proliferation of peroxisomes and the hepatocarcinogenic process].
Palut D
Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
[TBL] [Abstract][Full Text] [Related]
37. Rat 17 beta-hydroxysteroid dehydrogenase type IV is a novel peroxisome proliferator-inducible gene.
Corton JC; Bocos C; Moreno ES; Merritt A; Marsman DS; Sausen PJ; Cattley RC; Gustafsson JA
Mol Pharmacol; 1996 Nov; 50(5):1157-66. PubMed ID: 8913347
[TBL] [Abstract][Full Text] [Related]
38. Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis.
O'Brien ML; Rangwala SM; Henry KW; Weinberger C; Crick DC; Waechter CJ; Feller DR; Noonan DJ
Carcinogenesis; 1996 Feb; 17(2):185-90. PubMed ID: 8625436
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids.
Ruyter B; Andersen O; Dehli A; Ostlund Farrants AK; Gjøen T; Thomassen MS
Biochim Biophys Acta; 1997 Oct; 1348(3):331-8. PubMed ID: 9366249
[TBL] [Abstract][Full Text] [Related]
40. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
Tomaszewski KE; Agarwal DK; Melnick RL
Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
